With 1.3 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.03 million shares. The 52-week range on MNMD shows that it touched its highest point at $12.22 and its lowest point at $5.03 during that stretch. It currently has a 1-year price target of $24.50. Beta for the stock currently stands at 2.36.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MNMD was up-trending over the past week, with a rise of 1.69%, but this was down by -23.31% over a month. Three-month performance dropped to -10.90% while six-month performance rose 6.56%. The stock lost -29.61% in the past year, while it has lost -8.98% so far this year. A look at the trailing 12-month EPS for MNMD yields -1.91 with Next year EPS estimates of -1.55. For the next quarter, that number is -0.36. This implies an EPS growth rate of -2.36% for this year and 1.61% for next year. EPS is expected to grow by 8.04% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 12.11%.
Float and Shares Shorts:
At present, 75.10 million MNMD shares are outstanding with a float of 73.35 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MNMD since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.29502 being high and -$1.5595 being low. For MNMD, this leads to a yearly average estimate of -$1.43182. Based on analyst estimates, the high estimate for the next quarter is -$0.35 and the low estimate is -$0.41. The average estimate for the next quarter is thus -$0.39.
